Graymark Healthcare Reports Q1 Financial Results - Highlighted by Year-Over-Year Growth

(Financial Table Follows)

GRAYMARK HEALTHCARE, INC.

Reconciliation of EBITDA to Net Income

For the Quarters Ended March 31, 2010 and 2009

(unaudited)

2010

2009*

Net Revenues

$27,605,474

$25,471,393

Cost of Sales

(18,477,330)

(17,628,960)

Selling, general and administrative expenses

(9,343,943)

(6,803,354)

Non-controlling Interests

40,799

13,750

EBITDA

($   175,000)

$ 1,052,829

Reconciliation of EBITDA to net income

EBITDA

($   175,000)

$ 1,052,829

Depreciation and amortization

(607,432)

(514,439)

Interest and other expense, net

(594,531)

(520,874)

Provision for income taxes

(47,986)

-

Income from discontinued operations

-

2,197

Net income

($1,424,949)

$     19,713

*Certain 2009 amounts have been reclassified to conform to the current year presentation.